Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.95
Delayed Data
As of Sep 30
 +0.009 / +0.96%
Today’s Change
0.64
Today|||52-Week Range
1.97
-32.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-1.7M-3.7M-2.8M-4.3M
 
 
 
 
 
Depreciation135.9K313.9K52.3K7.0K
 
 
 
 
 
Total Other Cash Flow-135.9K1.4M500.8K2.5M
 
 
 
 
 
Funds From Operations-1.7M-2.0M-2.3M-1.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-235.9K482.3K163.7K16.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-1.5M-2.5M-2.4M-1.9M
 
 
 
 
 
 
InvestingIncrease In Investments-1.7M0.000.00-10.0K
 
 
 
Decrease In Investments0.003.4M1.5M21.0K
 
 
 
 
Capital Expenditures-6.0K-84.2K-7.9K-2.0K
 
 
 
 
 
Fixed Asset Disposal732.7K0.000.000.00
 
 
Net Assets From Acquisitions 0.000.000.00-55.0K
 
 
Other Investing - Uses-169.9K0.000.000.00
 
 
Other Investing - Sources999.600.000.000.00
 
 
Net Cash Flow Investing-1.2M3.3M1.5M-110.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale4.3M317.9K304.6K3.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.0020.0K
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.3M317.9K304.6K3.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash5.0K37.1K-13.8K-2.0K
 
 
 
 
 
 
Net Change In Cash1.6M1.2M-652.7K1.6M